Skip to main content

Market Overview

Why Progenity's Stock Is Trading Lower Today

Why Progenity's Stock Is Trading Lower Today

Progenity (NASDAQ: PROG) shares are trading lower on Monday after Wells Fargo downgraded the stock from Overweight to Underweight and lowered its price target from $11 to $5 per share.

Progenity is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.

Progenity shares were trading down 7.25% at $5.76. The stock has a 52-week high of $15.92 and low of $3.08.


Related Articles (PROG)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Small Cap

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at